Dr Jiri Pavlu began his medical career in 1998 after receiving a First Faculty of Medicine from Charles University in Prague and a doctorate of medicine from Charles University and St. George’s Hospital, London. He completed his haematological training at the Royal free and Hammersmith hospitals. Since then he has worked in the Imperial College NHS Trust providing consultant services to St. Mary’s and Hammersmith Hospitals.

Dr Pavlu took the position of Clinical Lead for Acute Leukaemia and myelodysplastic syndromes at Hammersmith Hospital in 2009. He is also the principal investigator of several acute leukaemia and transplantation trials.

Clinical expertise

Dr Jiri Pavlu specialises in:

  • blood cancer
  • leukaemia
  • general haematology (low haemoglobin, anaemia, abnormal high or low blood count, iron deficiency, iron overload, paraprotein investigation)
  • bone marrow transplantation (BMT)
  • myelodysplastic syndromes (MDS)
  • myeloproliferative neoplasms
  • acute leukemia
  • myeloma
  • lymphoma. 

He is the clinical lead for acute leukaemia and myelodysplastic syndromes and a stem cell transplant clinical and collection facility director.

Research interests 

Dr Jiri Pavlu has a specialist interest in the research of stem cell and bone marrow transplantation for leukaemia. 

He is a principal investigator and sub-investigator of various clinical trials, an active member of the European Group for Blood and Marrow Transplantation (EBMT), Acute leukaemia working party and also an accredited inspector for the Joint Accreditation Committee - International Society for Cellular Therapy (Europe) & EBMT.


See a list of Dr Pavlu's publications.